MTN-001 Study Schema.
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Formulations: Oral, 300 mg tenofovir disoproxil fumarate; Vaginal, 1% tenofovir gel. Sampling occurs at the 3-week mid-point (blood only) and 6-week end of period visit (blood, PBMC, vaginal biopsy [intensive sites], vaginal fluid, and rectal fluid [Bronx-Lebanon site]). Number of samples at each visit varied between intensive (US) and non-intensive (African) clinical sites.
创建时间：
2013-01-30
